Next |
home / stock / amrx / amrx message board
Subject | By | Source | When |
---|---|---|---|
MomentumIts gaining | dangerx | investorshub | 07/02/2023 10:42:27 PM |
best news of the day | ListenToMe | investorshub | 07/01/2023 1:35:40 PM |
$AMRX Price gaining | Elpapibh | investorshub | 06/29/2023 8:17:43 PM |
$AMRX MomentumIts now last trade up | ClayTrader | investorshub | 06/28/2023 2:43:21 PM |
$AMRX The gaining | ListenToMe | investorshub | 06/27/2023 2:57:17 PM |
Do we have a winner?Turn around time? | ListenToMe | investorshub | 06/24/2023 6:00:12 PM |
short squeeze signal | ListenToMe | investorshub | 06/23/2023 6:27:33 PM |
and the shorts continue | Elpapibh | investorshub | 06/23/2023 10:49:19 AM |
$AMRX Have a look at this | ListenToMe | investorshub | 06/23/2023 7:48:05 AM |
Price trading | Bngo | investorshub | 06/20/2023 8:45:46 PM |
$AMRX Found an interesting article | Elpapibh | investorshub | 06/20/2023 7:01:12 PM |
$AMRX Price now last up | ListenToMe | investorshub | 06/18/2023 11:21:46 PM |
MomentumIts trading | Bngo | investorshub | 06/18/2023 10:58:32 PM |
Good read | ListenToMe | investorshub | 06/17/2023 11:48:23 AM |
just the news we needed | ListenToMe | investorshub | 06/17/2023 6:55:17 AM |
$AMRX should we be shorting? | dangerx | investorshub | 06/16/2023 3:40:21 AM |
The now | dangerx | investorshub | 06/15/2023 2:18:15 PM |
are we finally gonna see some action | Luckypennyman | investorshub | 06/14/2023 10:14:14 PM |
Price now | Elpapibh | investorshub | 06/10/2023 5:07:06 AM |
$AMRX great article | dangerx | investorshub | 06/08/2023 4:00:04 AM |
News, Short Squeeze, Breakout and More Instantly...
Amneal Pharmaceuticals Inc. Class A Company Name:
AMRX Stock Symbol:
NYSE Market:
Amneal Pharmaceuticals Inc. Class A Website:
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its second quarter 2024 financial results on Friday, August 9, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time. ...
FOCINVEZ (fosaprepitant) 150 mg/50 mL single dose vial is an anti-nausea agent for highly emetogenic and moderately emetogenic chemotherapy (HEC and MEC) Second injectable RTU product launched by Amneal in 2024 Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal”...
Builds on successful U.S. biosimilar partnership of 2 oncology products (RELEUKO ® & FYLNETRA ® ) ADL018 is Kashiv’s lead pipeline biosimilar program, currently in Phase III Kashiv BioSciences, LLC (“Kashiv” or the “Companyȁ...